SEC-sourced researchBeta
RANI
Rani Therapeutics Holdings, Inc.
Company comparison ↗
Data passport
- CIK
- 0001856725
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Sep 29, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 1,028,000.0000 | Mar 26, 2026 |
| December 2025 | 1,633,000.0000 | Mar 26, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 1,633,000.0000 | -29,673,000.0000 | -18,714,000.0000 | 58,621,000.0000 | 17,109,000.0000 | Mar 26, 2026 |
| December 2024 | 1,028,000.0000 | -30,018,000.0000 | -35,496,000.0000 | 36,634,000.0000 | 33,141,000.0000 | Mar 26, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.63M | December 2025 | Mar 26, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.03M | December 2024 | Mar 26, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$29.67M | December 2025 | Mar 26, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$18.71M | December 2025 | Mar 26, 2026 | 10-K |
| Total assetsAssets | $58.62M | December 2025 | Mar 26, 2026 | 10-K |
| Total liabilitiesLiabilities | $17.11M | December 2025 | Mar 26, 2026 | 10-K |